FundingWatcher
Home / Investors / Biotech investors / Biotech investors in North America

Biotech investors in North America

Updated 16 Nov 2026

Reset

Venture funds

41 funds, by portfolio companies funded in the last 12 months
#FundSectorsStages LeadsFunded, 12 months
1 SOSV
SOSV provides early-stage funding for healthcare and environmental technologies, with recent investments including Opentrons and Prolific Machines.
Princeton, United States
Hardware, Artificial intelligence Seed, Early stage venture 41% 17
2 SOSV SF & NY (Fka IndieBio)
SOSV SF & NY, formerly IndieBio, supports deep tech founders, with recent investments including Prolific Machines and heXem bio.
San Francisco, United States
Biotech, Health care Seed, Early stage venture 3% 14
3 Alumni Ventures
Alumni Ventures offers accredited investors diversified startup portfolios, with recent investments including Coframe and Ocient.
Manchester, United States
Artificial intelligence, Fintech Seed, Early stage venture, Late stage venture 1% 7
4 Khosla Ventures
Khosla Ventures backs AI, sustainability, health and frontier technologies, with recent investments including Opentrons and Ramp.
Menlo Park, United States
Artificial intelligence, Health care Seed, Early stage venture, Late stage venture 39% 7
5 Alexandria Venture Investments
Alexandria Venture Investments invests in real estate technology and healthcare, with recent investments including Lycia Therapeutics and Aspen Neuroscience.
Pasadena, United States
Biotech, Health care Seed, Early stage venture, Late stage venture 7% 5
6 Mission BioCapital
Mission BioCapital invests in early-stage life science companies, with recent investments including Circle Pharma and Cloverleaf Bio.
Cambridge, United States
Biotech, Health care Seed, Early stage venture, Late stage venture 20% 4
7 Bristol-Myers Squibb
Bristol-Myers Squibb develops and sells pharmaceuticals, with recent investments including BigHat Biosciences and Ratio Therapeutics.
New York, United States
Biotech, Health care Early stage venture 30% 4
8 Gaingels
Gaingels funds startups and supports diversity and inclusion in entrepreneurship, with recent investments including Delix Therapeutics and Ocient.
Burlington, United States
Artificial intelligence, Fintech Seed, Early stage venture, Late stage venture 1% 4
9 Google Ventures
Google Ventures provides seed through growth-stage funding to technology companies, with recent investments including Harvey and SambaNova.
San Francisco, United States
Artificial intelligence, Hardware Seed, Early stage venture, Late stage venture 29% 4
10 ARCH Venture Partners
ARCH Venture Partners focuses on life science discoveries to prevent, detect and cure disease, with recent companies including Moonwalk Biosciences and Mirador Therapeutics.
Chicago, United States
Health care, Biotech Seed, Early stage venture, Late stage venture 27% 3
11 Conscience VC
Conscience VC invests in science, with recent companies Tiny Health and Integrated Biosciences.
Austin, United States
Health care, Biotech Seed, Early stage venture 8% 3
12 Fifty Years
Fifty Years backs entrepreneurs solving the world's biggest problems, recently investing in Multiply Labs and Aalo Atomics.
San Francisco, United States
Artificial intelligence, Health care Seed, Early stage venture, Late stage venture 19% 3
13 Joyance Partners
Joyance Partners invests in companies using science and technology to cultivate joy, with recent investments including Mosh and Sparxell.
San Francisco, United States
Health care, Biotech Seed, Early stage venture 8% 3
14 Modi Ventures
Modi Ventures focuses on investing into the next frontier, and recently backed Tiny Health and Latus Bio.
Houston, United States
Biotech, Health care Seed, Early stage venture, Late stage venture 14% 3
15 Pfizer
Pfizer is a biopharmaceutical company developing medicines and vaccines, with recent companies including Circle Pharma, CellCentric and FoRx Therapeutics.
New York, United States
Biotech, Health care 40% 3
16 The Column Group
The Column Group is a venture firm dedicated to biotechnology companies, with recent companies including Circle Pharma, InduPro and Atavistik Bio.
San Francisco, United States
Biotech, Health care Seed, Early stage venture, Late stage venture 39% 3
17 2048 Ventures
2048 Ventures is a thesis-driven venture firm, recently backing TwoStep Therapeutics and Genius AI.
New York, United States
Artificial intelligence, Fintech Seed, Early stage venture 67% 2
18 8VC
8VC structures capital deployments for technology companies, with recent investments including Sirona Medical and BigHat Biosciences.
Austin, United States
Artificial intelligence, Fintech Seed, Early stage venture, Late stage venture 30% 2
19 Alpha Wave Global
Alpha Wave Global operates across private equity, private credit, public markets and insurance, with recent investments in Moonwalk Biosciences and Cour Pharmaceuticals Development.
Miami, United States
Fintech, Artificial intelligence Seed, Early stage venture, Late stage venture 54% 2
20 Artis Ventures
Artis Ventures invests in companies at the intersection of technology, health and biology, including Delix Therapeutics and Ozlo Sleep.
San Francisco, United States
Health care, Hardware Seed, Early stage venture, Late stage venture 35% 2
21 BoxGroup
BoxGroup invests in early-stage technology companies, with recent investments including Nominal and Northwood Space.
New York, United States
Artificial intelligence, Fintech Seed, Early stage venture 5% 2
22 Builders VC
Builders VC invests where technology meets new business models to modernize antiquated industries, including Clay and Pie Systems.
San Francisco, United States
Artificial intelligence, Health care Early stage venture 34% 2
23 Casdin Capital
Casdin Capital does fundamental research investing in life sciences and healthcare, with recent companies Multiply Labs and Thyme Care.
New York, United States
Health care, Biotech Seed, Early stage venture, Late stage venture 15% 2
24 DCVC
DCVC invests in venture and private equity strategies, with recent backings including Mach Industries and Fortem Technologies.
Palo Alto, United States
Artificial intelligence, Hardware Seed, Early stage venture 19% 2
25 Decheng Capital
Decheng Capital provides capital to early and growth stage life science companies, with recent investments in YolTech Therapeutics and Phrontline Biopharma.
Menlo Park, United States
Biotech, Health care Seed, Early stage venture, Late stage venture 40% 2
26 Digitalis Ventures
Digitalis Ventures invests in solutions to complex problems in human and animal health, including T-Therapeutics and Reema Health.
New York, United States
Health care, Biotech Seed, Early stage venture, Late stage venture 16% 2
27 Dolby Family Ventures
Dolby Family Ventures backs early-stage technology companies, with recent investments including Delix Therapeutics, NeuroBionics and Ursa Major.
San Francisco, United States
Hardware, Health care Seed, Early stage venture, Late stage venture 7% 2
28 Everywhere Ventures
Everywhere Ventures invests in early-stage technology companies, with recent investments including VAMA and North.cloud.
New York, United States
Artificial intelligence, Fintech Early stage venture 2% 2
29 F-Prime
F-Prime invests in healthcare and technology, with recent companies including Albert Invent and Nocion Therapeutics.
Cambridge, United States
Health care, Fintech Seed, Early stage venture, Late stage venture 25% 2
30 Founders Fund
Founders Fund backs companies building new technologies, and recent investments include Nominal and Northwood Space.
San Francisco, United States
Artificial intelligence, Fintech Seed, Early stage venture, Late stage venture 31% 2
31 FoundersX Ventures
FoundersX Ventures is an AI-first venture capital firm, with recent companies Zafrens and Cognito Therapeutics.
Menlo Park, United States
Hardware, Artificial intelligence Early stage venture 14% 2
32 Insight Partners
Insight Partners invests in high-growth software and Internet startups, with recent investments including Coast and Reco.
New York, United States
Artificial intelligence, Fintech Seed, Early stage venture, Late stage venture 62% 2
33 LifeX Ventures
LifeX Ventures backs technologies that extend the longevity of people and planet, with recent companies including Dash Bio and Century Health.
New York, United States
Artificial intelligence, Health care 11% 2
34 Lumira Ventures
Lumira Ventures is a health care and life sciences venture capital firm, with recent companies Specific Biologics and Cour Pharmaceuticals Development.
Toronto, Canada
Biotech, Health care Seed, Early stage venture, Late stage venture 29% 2
35 MassVentures
MassVentures supports Massachusetts-based startups, with recent backings including Emvolon and EnVision Endoscopy.
Boston, United States
Health care, Hardware Seed, Early stage venture, Late stage venture 26% 2
36 Morningside
Morningside invests in companies with novel science and technology, recently backing Pelicargo and Cognito Therapeutics.
Newton, United States
Health care, Biotech 46% 2
37 Pareto Holdings
Pareto Holdings provides venture studio and early-stage funding services, with recent investments including Mural and Ryft.
New York, United States
Fintech, Artificial intelligence Seed, Early stage venture 2% 2
38 Pear VC
Pear VC focuses on pre-seed and seed technology companies, with recent companies including ImpriMed, Cognition and WindBorne Systems.
Menlo Park, United States
Artificial intelligence, Fintech Seed, Early stage venture, Late stage venture 19% 2
39 Prime Movers Lab
Prime Movers Lab invests in energy, transportation, infrastructure, manufacturing, human augmentation and agriculture, including Zafrens and Cognixion.
Jackson, United States
Biotech, Health care Seed, Early stage venture, Late stage venture 68% 2
40 Tau Ventures
Tau Ventures invests in digital health and automation companies such as cars, drones and robots, with recent backings including Biotia and Verbal.
Palo Alto, United States
Artificial intelligence, Health care Seed, Early stage venture, Late stage venture 5% 2
41 The Engine
The Engine supports new companies working on scientific and technological innovation, with recent companies including Hyperlight and Emvolon.
Cambridge, United States
Hardware, Health care Seed, Early stage venture 36% 2

Table 1. Biotech investors in North America: venture capital and micro VC funds ranked by biotech companies whose most recent round closed in the last 12 months. Leads is the share of all recorded investments where the fund was lead investor. Source: FundingWatcher. Data as of 16 November 2026.

Biotech investors in North America
One-time CSV
  • 468 firms, 456 with a website
  • 336 firm email addresses
  • 304 phone numbers
  • CRM-ready CSV, 15 columns
  • Download right after payment
With partner contacts
Compiled to order
  • The full list, plus the people who invest
  • Up to 2 partners per firm, compiled to order
  • Name, job title and LinkedIn where found
  • Verified direct email per person
  • List CSV at once, contacts CSV by mail within 24 hours
Download right after paymentFree 10-row sampleSecure checkout by Stripe

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

investors-sector-biotech-north-america.csv468 rows × 15 columns
InvestorTypeLocationEmailPhone
Y CombinatorStartup acceleratorMountain View, United States•••@ycombinator.com(415) •••
SOSVVenture capital firmPrinceton, United States•••@sosv.com
National Science FoundationEntrepreneurship programAlexandria, United States•••@nsf.gov(703) •••
RA Capital ManagementStartup incubatorBoston, United States•••@racap.com617.77•••
SOSV SF & NY (Fka IndieBio)Venture capital firmSan Francisco, United States•••@sosv.com
Alumni VenturesAngel groupManchester, United States•••@av.vc+1 603•••
MassChallengeStartup acceleratorBoston, United States•••@masschallenge.org
TechstarsStartup acceleratorNew York, United States•••@techstars.com+1 303•••

8 rows of the CSV in 5 of its 15 columns, email and phone masked.

investors-sector-biotech-north-america-contacts.csvUp to 2 verified partners per firm × 7 columns
FirmPersonTitleVerified emailLinkedIn
Y CombinatorG••• A•••General Partnerg•••@ycombinator.comIn the CSV
SOSVO••• R•••Managing General Partnero•••@sosv.comIn the CSV
RA Capital ManagementP••• K•••Managing Partnerp•••@racap.comIn the CSV
OrbiMedW••• P•••Managing Directorp•••@orbimed.comIn the CSV
TechstarsA••• B•••Managing Director NYC Programsa•••@techstars.comIn the CSV

5 verified partner contact rows from organizations on this list, names and emails masked.

468
Investors
336
With email
304
With phone
328
Active in the last 12 months

Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.

Biotech investors in North America

30 of 468, most investments first
30 rows
# Investor Type Location Invests in Latest portfolio companies Funded, 12 months Investments Lead Exits Email Phone LinkedIn
1 Y Combinator Startup accelerator Mountain View, United States Artificial intelligence, Fintech Kalshi, Opentrons, Reflex 225 8,719 3,692 783 •••@ycombinator.com (415) ••• In the CSV
2 SOSV Venture capital firm Princeton, United States Hardware, Artificial intelligence Opentrons, live2.ai, Prolific Machines 30 2,865 1,185 98 •••@sosv.com In the CSV
3 National Science Foundation Entrepreneurship program, Government investment office Alexandria, United States Hardware, Artificial intelligence Emvolon, Xona, MuukTest 36 4,642 4,419 269 •••@nsf.gov (703) ••• In the CSV
4 RA Capital Management Startup incubator, Private equity firm Boston, United States Health care, Biotech Delix Therapeutics, Superluminal Medicines, Claris Biotherapeutics 9 544 183 243 •••@racap.com 617.77••• In the CSV
5 SOSV SF & NY (Fka IndieBio) Venture capital firm San Francisco, United States Biotech, Health care Prolific Machines, heXem bio, BryoSphere 17 596 17 12 •••@sosv.com In the CSV
6 Alumni Ventures Angel group, Micro VC fund Manchester, United States Artificial intelligence, Fintech Coframe, Ocient, Formic 67 2,424 32 263 •••@av.vc +1 603••• In the CSV
7 OrbiMed Private equity firm New York, United States Health care, Biotech Triveni Bio, Windward Bio, Terremoto Biosciences 8 810 276 304 +1 (21••• In the CSV
8 MassChallenge Startup accelerator Boston, United States Artificial intelligence, Health care HELIOS, DrizzleX, ScribeUp 26 3,225 1,037 267 •••@masschallenge.org In the CSV
9 Techstars Startup accelerator New York, United States Artificial intelligence, Fintech Zipline International, Intuitivo, MuukTest 67 6,842 3,391 638 •••@techstars.com +1 303••• In the CSV
10 Alexandria Venture Investments Venture capital firm Pasadena, United States Biotech, Health care TwoStep Therapeutics, Lycia Therapeutics, Triveni Bio 5 318 21 68 •••@gmail.com 626.57••• In the CSV
11 Plug and Play Startup accelerator, Co-working space Sunnyvale, United States Artificial intelligence, Fintech Opsin, Helical Fusion, Reco 51 2,592 352 230 •••@pnptc.com +1 408••• In the CSV
12 Creative Destruction Lab Entrepreneurship program, University program Toronto, Canada Artificial intelligence, Hardware Specific Biologics, Circuit Mind, Xona 21 788 215 87 •••@creativedestructionlab.com (404) ••• In the CSV
13 ARCH Venture Partners Venture capital firm Chicago, United States Health care, Biotech Moonwalk Biosciences, Moleculent, Mirador Therapeutics 3 535 147 121 •••@archventure.com 773-38••• In the CSV
14 Andreessen Horowitz Venture capital firm Menlo Park, United States Artificial intelligence, Fintech Shield AI, Zipline International, Northwood Space 49 2,041 916 311 •••@a16z.com (650) ••• In the CSV
15 Khosla Ventures Venture capital firm Menlo Park, United States Artificial intelligence, Health care Coframe, Opentrons, Even Healthcare 25 1,479 575 208 •••@khoslaventures.com +1 650••• In the CSV
16 Google Ventures Corporate venture arm, Venture capital firm San Francisco, United States Artificial intelligence, Hardware Snorkel AI, Thatch, Harvey 20 1,331 392 304 In the CSV
17 National Institutes of Health Entrepreneurship program Bethesda, United States Health care, Biotech Ramona, Talus Bio, Samay 5 1,049 774 107 •••@od.nih.gov 301-49••• In the CSV
18 Bristol-Myers Squibb Venture capital firm New York, United States Biotech, Health care BigHat Biosciences, Ratio Therapeutics, Cour Pharmaceuticals Development 4 109 33 22 (212)5••• In the CSV
19 Pioneer Fund Startup accelerator Toronto, Canada Artificial intelligence, Fintech Vera Health, Ultra, Talus Bio 35 860 12 34 •••@pioneerfund.vc In the CSV
20 MedTech Innovator Startup accelerator Los Angeles, United States Health care, Biotech StimCardio, Dopl Technologies, INIA Biosciences 15 444 242 28 •••@medtechinnovator.org 310-70••• In the CSV
21 Versant Ventures Venture capital firm Menlo Park, United States Biotech, Health care Gate Bioscience, Borealis Biosciences, Kate Therapeutics 387 108 114 +1 415••• In the CSV
22 F-Prime Venture capital firm Cambridge, United States Health care, Fintech T-Therapeutics, Albert Invent, Immuneel Therapeutics 4 540 133 113 •••@fprimecapital.com In the CSV
23 New Enterprise Associates Venture capital firm Menlo Park, United States Hardware, Artificial intelligence Pathos, Together AI, Union.ai 5 2,398 826 670 •••@nea.com (650) ••• In the CSV
24 500 Global Startup accelerator, Micro VC fund Palo Alto, United States Fintech, Commerce Takenos, Daytona, Salary Hero 27 3,424 579 469 •••@500.co +1 415••• In the CSV
25 Insight Partners Private equity firm, Venture capital firm New York, United States Artificial intelligence, Fintech Coast, Reco, Island 17 1,349 833 335 •••@insightpartners.com 212-23••• In the CSV
26 Big Idea Ventures Startup accelerator, Micro VC fund New York, United States Biotech, Health care Standing Ovation, Seprify, Innocent Meat 3 194 110 9 •••@bigideaventures.com (415) ••• In the CSV
27 Gaingels Syndicate, Venture capital firm Burlington, United States Artificial intelligence, Fintech Delix Therapeutics, Ocient, Xona 24 1,384 10 146 +1 212••• In the CSV
28 Invus Private equity firm New York, United States Health care, Biotech Lycia Therapeutics, Triveni Bio 2 300 52 99 •••@invus.com +1 (21••• In the CSV
29 Polaris Partners Private equity firm, Venture capital firm Boston, United States Health care, Artificial intelligence Faro AI, Triveni Bio, Whisker Labs 3 754 215 207 •••@polarispartners.com +1 855••• In the CSV
30 Fidelity Investment bank Boston, United States Health care, Hardware Zipline International, Tenstorrent, SiMa.ai 7 586 178 285 +1-866••• In the CSV

Table 2. Biotech investors in North America: the first 30 by recorded investments with a website and a location. Email and phone are masked here and complete in the CSV. Source: FundingWatcher. Data as of 16 November 2026. Base: 468.

Most active in the last 12 months

By portfolio companies funded
#InvestorLocation Funded, 12 monthsPortfolioLatest
1 Y Combinator Mountain View, United States 225 3,060 Kalshi, Opentrons, Reflex
2 Alumni Ventures Manchester, United States 67 696 Coframe, Ocient, Formic
3 Techstars New York, United States 67 2,132 Zipline International, Intuitivo, MuukTest
4 Plug and Play Sunnyvale, United States 51 740 Opsin, Helical Fusion, Reco
5 Andreessen Horowitz Menlo Park, United States 49 462 Shield AI, Zipline International, Northwood Space
6 General Catalyst San Francisco, United States 38 344 Nominal, Tractian, StockGro
7 National Science Foundation Alexandria, United States 36 244 Emvolon, Xona, MuukTest
8 Pioneer Fund Toronto, Canada 35 290 Vera Health, Ultra, Talus Bio
9 Sequoia Capital Menlo Park, United States 32 429 Zipline International, Kalshi, Hex Technologies
10 Lightspeed Venture Partners Menlo Park, United States 31 378 Casap, Supabase, Snorkel AI
11 SOSV Princeton, United States 30 356 Opentrons, live2.ai, Prolific Machines
12 Tiger Global Management New York, United States 27 289 Harbinger, Easol, Mach9
13 500 Global Palo Alto, United States 27 1,023 Takenos, Daytona, Salary Hero
14 Liquid 2 Ventures San Francisco, United States 26 313 Zafrens, Tractian, Mach9
15 MassChallenge Boston, United States 26 325 HELIOS, DrizzleX, ScribeUp

Table 3. Biotech investors in North America: investors in the most companies whose most recent round falls in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Latest rounds in their portfolios

Newest first
10 rows
Company What they do Sector Location Last round Amount Date Total raised Investors on this list Employees Founded
Light Frame Light Frame builds core banking and portfolio management technology for wealth managers. Fintech Providence, United States Seed $5.1M 2026-11-10 $6.8M Half Court Ventures 1 to 10 2024
Nominal Nominal develops software platforms that help hardware engineering teams test, monitor, and analyze operational data. Software Los Angeles, United States Series C $240.0M 2026-11-09 $422.5M General Catalyst, Founders Fund, Lux Capital +2 251 to 500 2022
Delix Therapeutics Delix Therapeutics develops psychoplastogen therapies that promote neuroplasticity. Biotech Boston, United States Series C $100.0M 2026-11-09 $244.1M RA Capital Management, Dolby Family Ventures, Artis Ventures +1 11 to 50 2019
Coframe Coframe builds software that continuously improves websites and apps based on real-world performance data. Artificial intelligence San Francisco, United States Series A $25.0M 2026-11-09 $34.3M Alumni Ventures, Khosla Ventures, Soma Capital 11 to 50 2023
Shield AI Unicorn Shield AI develops AI-powered systems that enhance safety for service members and civilians. Artificial intelligence San Diego, United States Series H $2.0B 2026-11-05 $6.1B Andreessen Horowitz 1,001 to 5,000 2015
Zipline International Unicorn Zipline designs, manufactures, and operates drones that deliver medical products. Hardware South San Francisco, United States Series I $1.5B 2026-11-05 $3.6B Fidelity, Techstars, Andreessen Horowitz +2 1,001 to 5,000 2011
CesiumAstro CesiumAstro develops satellite communication systems and spacecraft solutions for aerospace, commercial, and defense customers. Hardware Austin, United States Series D $630.0M 2026-11-05 $1.7B Trousdale Ventures 501 to 1,000 2017
T-Therapeutics T-Therapeutics develops T cell receptor therapies, spun off from the University of Cambridge. Biotech Cambridge, United Kingdom Series B $133.0M 2026-11-05 $224.6M F-Prime, Digitalis Ventures 51 to 100 2022
Ocient Ocient analyzes petabyte to exabyte scale data sets for organizations. Hardware Chicago, United States Series C $100.0M 2026-11-05 $256.5M Valor Equity Partners, Alumni Ventures, Gaingels 101 to 250 2016
Firmly.ai Firmly.ai operates an agentic commerce platform for product discovery and checkout across AI and digital channels. Fintech Seattle, United States Series A $15.0M 2026-11-05 $17.0M FJ Labs 51 to 100 2019

Table 4. Biotech investors in North America: the 10 most recent rounds of companies they back. Source: FundingWatcher. Data as of 16 November 2026.

Portfolio sectors

Portfolio sectorsCompaniesShare
Software 15,986 80%
Artificial intelligence 5,231 26%
Fintech 3,525 18%
Hardware 2,955 15%
Health care 2,584 13%
Commerce 2,305 12%
Biotech 1,029 5%
Cybersecurity 1,029 5%
Education 982 5%
Energy 343 2%

Table 5. Biotech investors in North America: portfolio companies by sector. Source: FundingWatcher. Data as of 16 November 2026.

Investment stages

Table 6. Biotech investors in North America by stage they invest at. Source: FundingWatcher. Data as of 16 November 2026.

Countries

CountriesInvestorsShare
United States 441 94%
Canada 27 6%

Table 7. Biotech investors in North America by headquarters country. Source: FundingWatcher. Data as of 16 November 2026.

Cities

CitiesInvestorsShare
San Francisco 78 17%
New York 70 15%
Boston 33 7%
Menlo Park 30 6%
Palo Alto 24 5%
Cambridge 17 4%
Toronto 10 2%
Chicago 9 2%
Austin 8 2%
Montréal 7 1%
Bethesda 6 1%
San Diego 6 1%

Table 8. Biotech investors in North America by headquarters city. Source: FundingWatcher. Data as of 16 November 2026.

Founded

FoundedInvestorsShare
2020s 39 9%
2010s 209 46%
2000s 99 22%
1990s 49 11%
1980s 25 6%
1970s 10 2%

Table 9. Biotech investors in North America by founding decade. Source: FundingWatcher. Data as of 16 November 2026.

Method

Sources, fields and exclusions of both files: Method.

Questions

How many biotech investors in North America are on the list?
468, in the file dated 16 November 2026. 328 of them invested in a company whose most recent round falls in the last 12 months.
How many have an email address?
336 of the 468 carry an email address in the download and 304 a phone number.
What does the CSV contain?
One row per investor, 15 columns: name, types, stages, city, region, country, founded, website, linkedin, investments, funded_last_12m, exits, lead_investments, email, phone.
How much does the list cost?
$29 one-time for all 468 rows, no account. Every investor and every startup, two files, cost $99. With partner contacts, up to 2 per firm compiled to order and mailed within 24 hours, $199.
What arrives after payment?
At once: the CSV with 468 rows, 336 firm email addresses and 304 phone numbers, on the page after payment and by mail. The emails are the address a firm publishes: 233 of the 336 are inboxes such as info@ or contact@. No partner names.
Can I see rows before buying?
The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
How current is the data?
The file is dated 16 November 2026. The download link serves the current file each time it is opened.

Biotech investors in North America: 468 rows, CSV, $29 one-time.

At once: the CSV with 468 rows, 336 firm email addresses and 304 phone numbers, on the page after payment and by mail.

The emails are the address a firm publishes: 233 of the 336 are inboxes such as info@ or contact@. No partner names.

Columns: name, types, stages, city, region, country, founded, website, linkedin, investments, funded_last_12m, exits, lead_investments, email, phone.

With partner contacts: $199 one-time. List CSV right after payment; up to 2 verified partner emails per firm compiled to order within 24 hours.

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

Biotech investors by city in North America

Investor types in North America

Other portfolio sectors in North America

Biotech investors elsewhere

Biotech startups

Cite: FundingWatcher, 468 biotech investors in North America, 16 November 2026. https://fundingwatcher.com/investors/sector/biotech/north-america/